COGT

Cogent Biosciences, Inc.

CIK 0001622229 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations

$36.73

↑ 1.42 (4.02%)

as of Aug 21, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals

Key stats

Market Cap

$6.37B

P/E Ratio

-16.90

EPS

-2.16

Dividend Yield

Not covered

52W Position

78%

Beta

2.43

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

11.97

P/S

Not covered

EV/Revenue

Not covered

ROE

-70.8%

Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 78%

$11.60$43.73

Latest Financials

2025-12-31 FY

Revenue

–

Net Income

-$328.94M

Total Assets

$937.61M

Free Cash Flow

-$266.00M

COGT

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

COGT

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news